000 01124 a2200313 4500
005 20250512012944.0
264 0 _c19890922
008 198909s 0 0 eng d
022 _a0361-7742
040 _aNLM
_beng
_cNLM
100 1 _aKurth, K H
245 0 0 _aIntracavitary treatment of transitional cell carcinoma of the bladder: questions and lessons after 27 years of experience.
_h[electronic resource]
260 _bProgress in clinical and biological research
_c1989
300 _a125-45 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdministration, Intravesical
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aCarcinoma in Situ
_xdrug therapy
650 0 4 _aCarcinoma, Transitional Cell
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aNeoplasm Invasiveness
650 0 4 _aPrognosis
650 0 4 _aTime Factors
650 0 4 _aUrinary Bladder Neoplasms
_xdrug therapy
700 1 _aSylvester, R
700 1 _ade Pauw, M
700 1 _aten Kate, F
773 0 _tProgress in clinical and biological research
_gvol. 310
_gp. 125-45
999 _c2677894
_d2677894